News
-
-
-
-
-
-
PRESS RELEASE
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million. Shareholders approved the takeover, with payment in cash and Mirum common stock, plus milestone payments -
-
-
-